Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Szer

Showing results (171-180 of 195) with videos related to

Pageof 20
Sort By:
Leukemia|July 31, 2009
The BH3 mimetic compound, ABT-737, synergizes with a range of cytotoxic chemotherapy agents in chronic lymphocytic leukemiaK D Mason, S L Khaw, K C Rayeroux, et al.
Bone Marrow Transplantation|February 3, 2015
Older recipient age is paradoxically associated with a lower incidence of chronic GVHD in thymoglobulin recipients: a retrospective study exploring risk factors for GVHD in allogeneic transplantation with thymoglobulin GVHD prophylaxisA B M Lim, J Storek, A Beligaswatte, et al.
Internal Medicine Journal|January 29, 2011
Introduction to the Australian consensus guidelines for the management of neutropenic fever in adult cancer patients, 2010/2011. Australian Consensus Guidelines 2011 Steering CommitteeS Lingaratnam, M A Slavin, B Koczwara, et al.
Internal Medicine Journal|January 29, 2011
An Australian survey of clinical practices in management of neutropenic fever in adult cancer patients 2009S Lingaratnam, M A Slavin, L Mileshkin, et al.
British Journal of Haematology|March 1, 1997
Mobilization of predominantly Philadelphia chromosome-negative blood progenitors using cyclophosphamide and rHUG-CSF in early chronic-phase chronic myeloid leukaemia: correlation with Sokal prognostic index and haematological controlT P Hughes, A Grigg, J Szer, et al.
Bone Marrow Transplantation|April 30, 2014
Challenges and opportunities for HSCT outcome registries: perspective from international HSCT registries expertsM Aljurf, J D Rizzo, M Mohty, et al.
Internal Medicine Journal|March 5, 2015
Treatment of patients with multiple myeloma who are not eligible for stem cell transplantation: position statement of the myeloma foundation of Australia Medical and Scientific Advisory GroupH Quach, D Joshua, J Ho, et al.
Internal Medicine Journal|January 14, 2015
Treatment of patients with multiple myeloma who are eligible for stem cell transplantation: position statement of the Myeloma Foundation of Australia Medical and Scientific Advisory GroupH Quach, D Joshua, J Ho, et al.
Bone Marrow Transplantation|March 8, 2012
Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantationN S Majhail, J D Rizzo, S J Lee, et al.
Hematology/Oncology and Stem Cell Therapy|March 27, 2012
Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantationN S Majhail, J D Rizzo, S J Lee, et al.
Pageof 20

Showing results (171-180 of 195) with videos related to

Sort By:
Pageof 20
Leukemia|July 31, 2009
The BH3 mimetic compound, ABT-737, synergizes with a range of cytotoxic chemotherapy agents in chronic lymphocytic leukemiaK D Mason, S L Khaw, K C Rayeroux, et al.
Bone Marrow Transplantation|February 3, 2015
Older recipient age is paradoxically associated with a lower incidence of chronic GVHD in thymoglobulin recipients: a retrospective study exploring risk factors for GVHD in allogeneic transplantation with thymoglobulin GVHD prophylaxisA B M Lim, J Storek, A Beligaswatte, et al.
Internal Medicine Journal|January 29, 2011
Introduction to the Australian consensus guidelines for the management of neutropenic fever in adult cancer patients, 2010/2011. Australian Consensus Guidelines 2011 Steering CommitteeS Lingaratnam, M A Slavin, B Koczwara, et al.
Internal Medicine Journal|January 29, 2011
An Australian survey of clinical practices in management of neutropenic fever in adult cancer patients 2009S Lingaratnam, M A Slavin, L Mileshkin, et al.
British Journal of Haematology|March 1, 1997
Mobilization of predominantly Philadelphia chromosome-negative blood progenitors using cyclophosphamide and rHUG-CSF in early chronic-phase chronic myeloid leukaemia: correlation with Sokal prognostic index and haematological controlT P Hughes, A Grigg, J Szer, et al.
Bone Marrow Transplantation|April 30, 2014
Challenges and opportunities for HSCT outcome registries: perspective from international HSCT registries expertsM Aljurf, J D Rizzo, M Mohty, et al.
Internal Medicine Journal|March 5, 2015
Treatment of patients with multiple myeloma who are not eligible for stem cell transplantation: position statement of the myeloma foundation of Australia Medical and Scientific Advisory GroupH Quach, D Joshua, J Ho, et al.
Internal Medicine Journal|January 14, 2015
Treatment of patients with multiple myeloma who are eligible for stem cell transplantation: position statement of the Myeloma Foundation of Australia Medical and Scientific Advisory GroupH Quach, D Joshua, J Ho, et al.
Bone Marrow Transplantation|March 8, 2012
Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantationN S Majhail, J D Rizzo, S J Lee, et al.
Hematology/Oncology and Stem Cell Therapy|March 27, 2012
Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantationN S Majhail, J D Rizzo, S J Lee, et al.
Pageof 20